Phase 3 Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have read and signed a consent form before any screening, and you are willing to have an HIV test
- You are between 18 and 65 years old and weigh between 50 kg (110 lbs) and 90 kg (198 lbs)
- Your TB treatment worked well and your sputum (mucus) test came back negative at week 16 of treatment
- You have completed a full 24-week (6-month) course of standard TB treatment
- You have been officially declared "cured" of TB by the South African TB Control Program
- If you are HIV-positive: you have been on HIV treatment (antiretroviral therapy) for at least 12 weeks and your HIV viral load is undetectable within the last 30 days
- If you are HIV-positive: your immune cell count (CD4) is above 350 cells/µL within the last 30 days
- Your liver enzyme levels (AST and ALT) are within an acceptable range based on a blood test taken within the last 30 days
- Your kidney function level (creatinine) is within an acceptable range based on a recent blood test
- Your haemoglobin (a measure of healthy red blood cells) is above a minimum level
- Your platelet count (cells that help blood clot) is above a minimum level
- Your creatinine kinase level (a muscle-related marker) is within an acceptable range
- You are able and willing to come back for follow-up visits
- You are willing to have biological samples, including DNA, stored for research
- You are willing to use a reliable method of contraception consistently throughout the trial
Who may not be able to join:
- You are currently suffering from an acute (sudden or short-term) illness
- You currently have a fever above 38°C (100.4°F)
- You are currently taking, have taken in the last 3 months, or are likely to need cholesterol-lowering medication (such as statins)
- You have a known allergy or medical reason to avoid the study drug or any statin medications
- You have drug-resistant TB
- Your TB has spread outside the lungs, including to the lining around the lungs (confirm with trial site)
- You are pregnant or planning to become pregnant in the next 6 months
- You are unable to swallow and take oral (by mouth) medications
- You have diabetes, as determined by specific blood sugar test results or by currently using any diabetes medication, including traditional medicines
- You have a long-term illness or complication that could affect your safety or the trial results, such as a known chronic inflammatory condition (for example, rheumatoid arthritis or sarcoidosis)
- You have used immune-suppressing medications (such as steroids or certain biologic drugs) within the past 2 weeks
- You have taken part in another clinical drug trial within the past 3 months
- You have issues with alcohol or substance use that might make it difficult to take medications regularly during the trial
- Your doctor feels this study is not appropriate for you for any reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Friedrich Thienemann, MD, University of Cape Town
Phone: +27 21 406 6358
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Total lung glycolysis (TLG) on PET/CT imaging
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.